GlassScriptPhysician profile
Alan W Bickel
NPI 1689679144
$18,473.59
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $420 · 2020: $124 · 2021: $215 · 2022: $525 · 2023: $17K · 2024: $37.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $16K · Food and Beverage: $893.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $16,296.62 |
| Food and Beverage | $892.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $16,296.62 | 2023 | Single Use Suction Valve (Sterile), Cysto-Nephro Videoscope |
| Angiodynamics, INC. | $540.91 | 2021-2023 | Nanoknife |
| Astellas Pharma US INC | $491.39 | 2019-2023 | Xtandi |
| Abbvie INC. | $159.62 | 2020-2024 | Botox, Lupron Depot |
| Boston Scientific Corporation | $107.17 | 2019-2023 | Rezum Generator, Lithovue |
| Myovant Sciences INC. | $95.12 | 2021-2022 | |
| Medtronic, INC. | $90.16 | 2021 | |
| Sumitomo Pharma America, INC. | $85.83 | 2023 | Orgovyx |
| Janssen Biotech, INC. | $80.52 | 2019-2023 | Erleada |
| Pfizer INC. | $57.82 | 2019-2023 | |
| Philips North America LLC | $56.70 | 2022 | |
| Ferring Pharmaceuticals INC. | $50.57 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $43.34 | 2022-2023 | Seglentis |
| Dendreon Pharmaceuticals LLC | $34.75 | 2022 | |
| Urogen Pharma, INC. | $32.57 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $31.15 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $31.00 | 2023 | Lynparza, Keytruda, Welireg |
| Agiliti Surgical, INC. | $27.94 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $27.30 | 2021 | |
| Coloplast Corp | $26.64 | 2020-2022 | |
| Axonics, INC. | $22.76 | 2022 | |
| Endo USA, INC. | $20.38 | 2024 | Xiaflex |
| Procept Biorobotics Corporation | $18.85 | 2022 | |
| Baxter Healthcare | $18.69 | 2021 | |
| Medtronic USA, INC. | $14.35 | 2019 | |
| 180 Medical, INC. | $11.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Bickel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.